Worldwide Vaccine Vial Monitor Industry to 2026 - Abrupt Rise in COVID-19 Infection Across Geographies Presents Opportunities
January 05, 2022 03:58 ET
|
Research and Markets
Dublin, Jan. 05, 2022 (GLOBE NEWSWIRE) -- The "Vaccine Vial Monitor Market Research Report by Type (Multi-dose and Single Dose), by Application (Preventive Vaccine and Therapeutic Vaccine), by...
Global Vaccine Market Report 2021: Market is Valued at $187 Billion in 2021, with COVID-19 Vaccines Contributing $137 billion
December 14, 2021 08:38 ET
|
Research and Markets
Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "Vaccines Market by Indication, Route of Administration, Type, Valence - Global Forecast to 2028" report has been added to ResearchAndMarkets.com's...
Global Vaccine Technologies Market Forecasts to 2026: Live-attenuated Vaccine Technology Market is Forecast to Grow from $7.1 billion in 2021 to $10.2 billion by 2026
December 03, 2021 06:08 ET
|
Research and Markets
Dublin, Dec. 03, 2021 (GLOBE NEWSWIRE) -- The "Global Markets for Vaccine Technologies 2021-2026" report has been added to ResearchAndMarkets.com's offering. Growth in the vaccine market is...
mRNA Therapeutics and Vaccines Market, 2030
March 25, 2021 06:03 ET
|
Research and Markets
Dublin, March 25, 2021 (GLOBE NEWSWIRE) -- The "mRNA Therapeutics and Vaccines Market, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The "mRNA Therapeutics and Vaccines...
United States Vaccine Vials (Multi Dose and Single Dose) Market Report 2021-2025: Type, Material, Capacity, Application - Cumulative Impact of COVID-19
February 11, 2021 07:28 ET
|
Research and Markets
Dublin, Feb. 11, 2021 (GLOBE NEWSWIRE) -- The "Vaccine Vials Market Research Report by Type (Multi Dose and Single Dose), by Material (Glass and Polymer), by Capacity, by Application - United States...
COVID-19 Vaccine & Therapeutics Clinical Trial Analysis Report 2020
November 18, 2020 03:13 ET
|
Research and Markets
Dublin, Nov. 18, 2020 (GLOBE NEWSWIRE) -- The "COVID-19 Vaccine & Therapeutics Clinical Trial Analysis 2020" report has been added to ResearchAndMarkets.com's offering. Major players in the...
VBI Vaccines Announces Third Positive DSMB Review in Phase 1/2a Study of VBI-1901 in Recurrent GBM Patients
February 07, 2019 08:00 ET
|
VBI Vaccines, Inc.
Independent Data and Safety Monitoring Board (DSMB) unanimously recommends continuation of the study without modificationEnrollment is complete in the high-dose study arm of Part AExpanded immunologic...
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017
November 10, 2017 08:00 ET
|
VBI Vaccines, Inc.
New data confirms use of intradermal delivery of eVLPs may be a potent “off-the-shelf” immunotherapy vaccinePoster presentation at the Society for Immunotherapy of Cancer’s (SITC) 32nd Annual Meeting...
Bionor Pharma's Phase II Vacc-4x Data Published in the Lancet Infectious Diseases
February 11, 2014 09:27 ET
|
Bionor Pharma
OSLO, NORWAY--(Marketwired - Feb 11, 2014) - Bionor Pharma ASA (OSE: BIONOR) announces that the results from the randomized, multicenter, double-blinded, placebo-controlled Phase II trial with 135...
Successful Immunization and Safety Documented in Nasal Administration Study of the HIV Vaccine Vacc-4x Together With Endocine
May 10, 2012 06:47 ET
|
Bionor Pharma
OSLO, NORWAY--(Marketwire - May 10, 2012) - Bionor Pharma (OSLO: BIONOR)
News Summary
Vaccine related immune responses found in HIV patients given Vacc-4x...